These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36347556)

  • 1. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
    Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
    Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
    Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
    Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora.
    Lim DG; Jung SI; Kim MS; Chung HS; Hwang EC; Kwon DD
    Prostate Int; 2021 Sep; 9(3):163-168. PubMed ID: 34692590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
    Krsakova E; Cermak A; Fedorko M
    J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
    Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
    World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
    Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
    J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.
    Kisa E; Altug MU; Gurbuz OA; Ozdemir H
    Int Braz J Urol; 2017; 43(6):1068-1074. PubMed ID: 28727372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
    Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
    World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.